Cargando…

Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients

The Visual Functioning-14 (VF-14) scale is the most widely employed index of vision-related functional impairment and serves as a patient-reported outcome measure in vision-specific quality of life. The purpose of this study is to rigorously examine and validate the VF-14 scale on a Greek population...

Descripción completa

Detalles Bibliográficos
Autores principales: Mylona, Ioanna, Aletras, Vassilis, Ziakas, Nikolaos, Tsinopoulos, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072548/
https://www.ncbi.nlm.nih.gov/pubmed/33923803
http://dx.doi.org/10.3390/ijerph18084254
_version_ 1783683932217147392
author Mylona, Ioanna
Aletras, Vassilis
Ziakas, Nikolaos
Tsinopoulos, Ioannis
author_facet Mylona, Ioanna
Aletras, Vassilis
Ziakas, Nikolaos
Tsinopoulos, Ioannis
author_sort Mylona, Ioanna
collection PubMed
description The Visual Functioning-14 (VF-14) scale is the most widely employed index of vision-related functional impairment and serves as a patient-reported outcome measure in vision-specific quality of life. The purpose of this study is to rigorously examine and validate the VF-14 scale on a Greek population of ophthalmic patients employing Rasch measurement techniques. Two cohorts of patients were sampled in two waves. The first cohort included 150 cataract patients and the second 150 patients with other ophthalmic diseases. The patients were sampled first while pending surgical or other corrective therapy and two months after receiving therapy. The original 14-item VF-14 demonstrated poor measurement precision and disordered response category thresholds. A revised eight-item version, the VF-8G (‘G’ for ‘Greek’), was tested and confirmed for validity in the cataract research population. No differential functioning was reported for gender, age, and underlying disorder. Improvement in the revised scale correlated with improvement in the mental and physical component of the general health scale SF-36. In conclusion, our findings support the use of the revised form of the VF-14 for assessment of vision-specific functioning and quality of life improvement in populations with cataracts and other visual diseases than cataracts, a result that has not been statistically confirmed previously.
format Online
Article
Text
id pubmed-8072548
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80725482021-04-27 Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients Mylona, Ioanna Aletras, Vassilis Ziakas, Nikolaos Tsinopoulos, Ioannis Int J Environ Res Public Health Article The Visual Functioning-14 (VF-14) scale is the most widely employed index of vision-related functional impairment and serves as a patient-reported outcome measure in vision-specific quality of life. The purpose of this study is to rigorously examine and validate the VF-14 scale on a Greek population of ophthalmic patients employing Rasch measurement techniques. Two cohorts of patients were sampled in two waves. The first cohort included 150 cataract patients and the second 150 patients with other ophthalmic diseases. The patients were sampled first while pending surgical or other corrective therapy and two months after receiving therapy. The original 14-item VF-14 demonstrated poor measurement precision and disordered response category thresholds. A revised eight-item version, the VF-8G (‘G’ for ‘Greek’), was tested and confirmed for validity in the cataract research population. No differential functioning was reported for gender, age, and underlying disorder. Improvement in the revised scale correlated with improvement in the mental and physical component of the general health scale SF-36. In conclusion, our findings support the use of the revised form of the VF-14 for assessment of vision-specific functioning and quality of life improvement in populations with cataracts and other visual diseases than cataracts, a result that has not been statistically confirmed previously. MDPI 2021-04-16 /pmc/articles/PMC8072548/ /pubmed/33923803 http://dx.doi.org/10.3390/ijerph18084254 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mylona, Ioanna
Aletras, Vassilis
Ziakas, Nikolaos
Tsinopoulos, Ioannis
Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients
title Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients
title_full Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients
title_fullStr Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients
title_full_unstemmed Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients
title_short Rasch Validation of the VF-14 Scale of Vision-Specific Functioning in Greek Patients
title_sort rasch validation of the vf-14 scale of vision-specific functioning in greek patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072548/
https://www.ncbi.nlm.nih.gov/pubmed/33923803
http://dx.doi.org/10.3390/ijerph18084254
work_keys_str_mv AT mylonaioanna raschvalidationofthevf14scaleofvisionspecificfunctioningingreekpatients
AT aletrasvassilis raschvalidationofthevf14scaleofvisionspecificfunctioningingreekpatients
AT ziakasnikolaos raschvalidationofthevf14scaleofvisionspecificfunctioningingreekpatients
AT tsinopoulosioannis raschvalidationofthevf14scaleofvisionspecificfunctioningingreekpatients